Citation: S. Dastmalchi et al., Modeling of the structural features of integral-membrane proteins using reverse-environment prediction of integral membrane protein structure (REPIMPS), PROTEIN SCI, 10(8), 2001, pp. 1529-1538
Authors:
Church, WB
Inglis, AS
Tseng, A
Duell, R
Lei, PW
Bryant, KJ
Scott, KF
Citation: Wb. Church et al., A novel approach to the design of inhibitors of human secreted phospholipase A(2) based on native peptide inhibition, J BIOL CHEM, 276(35), 2001, pp. 33156-33164
Citation: Wb. Church et al., Crystallization and preliminary X-ray diffraction studies of a new crystalform of human secretory type IIA phospholipase A(2), ACT CRYST D, 56, 2000, pp. 1482-1484
Authors:
McCaughan, GW
Gorrel, MD
Bishop, GA
Abbott, CA
Shackel, NA
McGuinness, PH
Levy, MT
Sharland, AF
Bowen, DG
Yu, D
Slaitini, L
Church, WB
Napoli, J
Citation: Gw. Mccaughan et al., Molecular pathogenesis of liver disease: an approach to hepatic inflammation, cirrhosis and liver transplant tolerance, IMMUNOL REV, 174, 2000, pp. 172-191
Authors:
Iismaa, SE
Wu, MJ
Nanda, N
Church, WB
Graham, RM
Citation: Se. Iismaa et al., GTP binding and signaling by G(h)/transglutaminase II involves distinct residues in a unique GTP-binding pocket, J BIOL CHEM, 275(24), 2000, pp. 18259-18265
Authors:
Sharer, JD
Koosha, H
Church, WB
March, PE
Citation: Jd. Sharer et al., The function of conserved amino acid residues adjacent to the effector domain in elongation factor G, PROTEINS, 37(2), 1999, pp. 293-302
Citation: Ca. Abbott et al., Binding to human dipeptidyl peptidase IV by adenosine deaminase and antibodies that inhibit ligand binding involves overlapping, discontinuous sites on a predicted beta propeller domain, EUR J BIOCH, 266(3), 1999, pp. 798-810